Substituted purine compounds
US9688714B2 · kind B2 · utility
5Cited by
2References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 3, 2014 |
| Grant date | Jun 27, 2017 |
| Priority date | — |
| Expiry date | Jul 3, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to substituted purine compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating disorders in which DOT1-mediated protein methylation plays a part, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.